Clorox (NYSE:CLX) Price Target Lowered to $169.00 at DA Davidson

Clorox (NYSE:CLX - Free Report) had its target price trimmed by DA Davidson from $171.00 to $169.00 in a research note published on Wednesday morning,Benzinga reports. The firm currently has a neutral rating on the stock. DA Davidson also issued estimates for Clorox's FY2025 earnings at $6.65 EPS and FY2026 earnings at $6.32 EPS.

Several other brokerages have also recently issued reports on CLX. Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday. Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and upped their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox presently has an average rating of "Hold" and a consensus target price of $158.21.

Clorox Trading Up 0.6 %

NYSE:CLX traded up $0.91 during trading hours on Wednesday, reaching $148.51. The company's stock had a trading volume of 1,074,015 shares, compared to its average volume of 1,380,263. The firm has a 50-day simple moving average of $161.06 and a 200-day simple moving average of $158.70. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37. The firm has a market capitalization of $18.38 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company posted $2.16 earnings per share. Research analysts expect that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is currently 133.33%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CLX. State Street Corp lifted its position in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC increased its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Stifel Financial Corp boosted its position in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock valued at $380,370,000 after acquiring an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp grew its holdings in shares of Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after purchasing an additional 31,510 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.